NEWS

nemagen.jpg

We are excited to welcome NemaGen Discoveries to  portfolio of companies in which we have invested. Founded by Mark C. Siracusa, PhD, Assistant Professor at Rutgers New Jersey Medical School, NemaGen is focused on advancing therapies to prevent allergic inflammation and mast-cell related diseases.

Capture.JPG

Congratulations to Kayothera, Inc. (a Foundation Venture Capital Group portfolio company), the BIO 2021 Start-up Stadium Winner!  

Visikol.jpg

We are excited to share the news that Visikol has been acquired by CELLINK.